These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12723505)

  • 1. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
    Hansen HH; Sørensen JB
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
    Vander Els NJ; Miller V
    Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
    Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
    Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-induced severe pulmonary toxicity.
    Barlési F; Villani P; Doddoli C; Gimenez C; Kleisbauer JP
    Fundam Clin Pharmacol; 2004 Feb; 18(1):85-91. PubMed ID: 14748759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
    Kouroussis C; Mavroudis D; Kakolyris S; Voloudaki A; Kalbakis K; Souglakos J; Agelaki S; Malas K; Bozionelou V; Georgoulias V
    Lung Cancer; 2004 Jun; 44(3):363-8. PubMed ID: 15140550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.
    Chen YM; Chen MC; Tsai CM; Perng RP
    Lung Cancer; 2003 Apr; 40(1):99-101. PubMed ID: 12660014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
    Gatzemeier U; Manegold C; Eberhard W; Wilke HJ; Chomy F; Chomy P; Khayat D; Blatter J; Seeber S; Drings P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-36-S8-38. PubMed ID: 9207315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
    Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.
    Ng EW; Sandler AB; Robinson L; Einhorn LH
    Am J Clin Oncol; 1999 Dec; 22(6):550-3. PubMed ID: 10597737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
    Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: a Hoosier Oncology Group study.
    Einhorn LH
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-24-S8-26. PubMed ID: 9207312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of gemcitabine in lung cancer: part I.
    Bunn PA
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.
    Shepherd FA; Abratt RP; Anderson H; Gatzemeier U; Anglin G; Iglesias J
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-50-S7-55. PubMed ID: 9194481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).
    Ferrigno D; Buccheri G;
    Lung Cancer; 2004 Sep; 45(3):373-80. PubMed ID: 15301878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
    Le Chevalier T; Gottfried M
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.